Oncology Blogs

06|13|25

AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era

At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]

06|10|25

AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025 

At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care. 

04|30|25

More Complexity, Less Protection: Why Oncology Brands are Redefining for Survival

The pace of change in oncology is accelerating—and with it, the pressure on brands to adapt. From scientific advancements and precision medicine to shifting standards of care and practice consolidation, oncology is no longer just complex—it’s chaotic. Oncologists are overwhelmed and the once-protected status of oncology is now in question. Brands that fail to evolve […]

09|27|24

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Every year, ESMO brings together experts from pharma, research and advocacy organizations, and HCPs to hear about the year’s biggest oncology breakthroughs. This year’s theme was “Shaping the Future of Anticancer Therapies.”